Precision Medicine for L/GCMN and Melanoma 2

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

December 1, 2026

Conditions
Melanoma (Skin Cancer)Nevi and MelanomasCongenital Melanocytic Nevus
Interventions
DEVICE

Breath analyzer

The study subject will be advised to sit quietly for minimum 10 minutes prior the sampling to avoid temporal changes in levels of volatile organic compunds (VOCs) related to body movement or try to avoid abrupt changes in body posture. Then, he/she will be asked to blow in the breath analyzer in order to obtain the exhaled VOCs profile.

DEVICE

Skin patch

A skin patch will be placed in the anterior part of the patient's arm for the obtention of the skin VOCs profile (estimated sampling time of around 1 h). These profiles will be recorded with a dedicated software and analyzed using standard statistical methods.

GENETIC

Liquid biopsy

Circulating free tumor DNA (cfDNA) will be extracted from patient's blood and analyzed to detect mutations in BRAF and other prognostic genes.

Trial Locations (3)

08036

NOT_YET_RECRUITING

Hospital Clínic de Barcelona (Dermatology service), Barcelona

Unknown

RECRUITING

Hospital Clínic Barcelona, Barcelona

RECRUITING

Hospital Clínic Barcelona, Barcelona

All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

lead

Fundacion Clinic per a la Recerca Biomédica

OTHER